LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 135 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $177,000 | -63.8% | 14,400 | -51.5% | 0.06% | -57.9% |
| Q2 2017 | $489,000 | -2.2% | 29,710 | -14.8% | 0.14% | +17.6% |
| Q1 2017 | $500,000 | +3.7% | 34,870 | 0.0% | 0.12% | +8.2% |
| Q4 2016 | $482,000 | -24.9% | 34,870 | -1.9% | 0.11% | -27.6% |
| Q3 2016 | $642,000 | – | 35,540 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |